SCHEMBL19620561

SCHEMBL19620561

NC1=C(OSCc2ccccc2)C(=O)C(c2nccs2)O1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.34
USP2 O75604 1/20 0.34
LMNA P02545 1/20 0.34
TSHR P16473 1/20 0.34
PTPRC P08575 1/20 0.32
NOS3 P29474 1/20 0.31
NOS2 P35228 1/20 0.31
MAPT P10636 2/20 0.31
KDM4E B2RXH2 1/20 0.31
POLB P06746 1/20 0.31
PKM P14618 2/20 0.31
GAA P10253 2/20 0.30
MGAM O43451 1/20 0.30
SI P14410 1/20 0.30
MGAM2 Q2M2H8 1/20 0.30
CYP1A2 P05177 1/20 0.30
CYP3A4 P08684 1/20 0.30
CYP2C19 P33261 1/20 0.30
ALDH1A1 P00352 1/20 0.30
TDP1 Q9NUW8 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19620550 0.81 KMT2A (0.39) SMN1; SMN2MAPTKDM4EPOLBCYP1A2
SCHEMBL19620491 0.81 KDM4E (0.35) SMN1; SMN2USP2TSHRPTPRCMAPT
SCHEMBL19620603 0.80 POLB (0.50) SMN1; SMN2LMNAMAPTKDM4EPOLB
SCHEMBL19620533 0.79 MAPT (0.42) SMN1; SMN2USP2MAPTKDM4EPOLB
SCHEMBL15627559 0.79 KMT2A (0.38) LMNANOS3NOS2MAPTKDM4E
SCHEMBL19620650 0.77 CYP19A1 (0.42) SMN1; SMN2USP2LMNATSHRMAPT
SCHEMBL19620504 0.76 TP53 (0.43) SMN1; SMN2TSHRMAPTKDM4ECYP1A2
SCHEMBL15619870 0.75 METAP2 (0.34) SMN1; SMN2LMNANOS3NOS2MAPT
SCHEMBL19620675 0.74 MAPT (0.42) SMN1; SMN2LMNAMAPTKDM4EPOLB
SCHEMBL19620528 0.74 DPP4 (0.36) SMN1; SMN2TSHRMAPTKDM4EPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3345596-B1 INHIBITORS OF BETA-HYDROLASE FOR TREATMENT OF CANCER RHODE ISLAND HOSPITAL (US) 2021-01-20 EP disclosed
EP-3345596-A2 INHIBITORS OF BETA-HYDROLASE FOR TREATMENT OF CANCER RHODE ISLAND HOSPITAL (US) 2018-07-11 EP disclosed
EP-2897607-B1 INHIBITORS OF BETA-HYDROLASE FOR TREATMENT OF CANCER RHODE ISLAND HOSPITAL (US) 2017-11-22 EP disclosed